Standout Papers

Resistance to therapy caused by intragenic deletion in BRCA2 2008 2026 2014 2020 738
  1. Resistance to therapy caused by intragenic deletion in BRCA2 (2008)
    Stacey L. Edwards, Rachel Brough et al. Nature

Immediate Impact

1 by Nobel laureates 18 from Science/Nature 86 standout
Sub-graph 1 of 14

Citing Papers

PARP and PARG inhibitors in cancer treatment
2020 Standout
Clinical actionability of molecular targets in endometrial cancer
2019 Standout
68 intermediate papers

Works of Radost Vatcheva being referenced

PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
2010
Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas
2009
and 3 more

Author Peers

Author Last Decade Papers Cites
Radost Vatcheva 1581 956 506 19 2.2k
Wataru Sakai 1734 1478 521 24 2.3k
Tatiana Popova 1498 799 519 36 2.4k
Louise J. Barber 1677 680 266 29 2.1k
Céline Jacquemont 1150 978 345 22 1.6k
Rémi Buisson 2091 883 350 43 2.4k
Rachel Brough 2302 2016 475 39 3.0k
Samuel F. Bunting 2054 956 290 30 2.5k
Maria Jasin 2809 710 852 23 3.1k
Jennifer E. Quinn 1097 691 550 23 1.7k
Aaron Cranston 1843 1752 462 41 2.7k

All Works

Loading papers...

Rankless by CCL
2026